BioSpace News Archive

Seasoned medical device professional joins leading European neuromodulation start-up

PharmOptima, a member of Genesis Drug Discovery & Development, the contract research organization arm of Genesis Biotechnology Group®, has announced the appointment of Anthony Rohr as its new Chief Executive Officer.

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that the company will host a conference call and live audio webcast on Tuesday, August 11, 2020, at 8:30 a.m. ET to review its second quarter 2020 financial results and provide an update on the company. The webcast will be available on the “Investors & Media” section of the Gam

American CryoStem Corporation is pleased to issue the following shareholder update letter from Chief Executive Officer John Arnone.

RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), has historically been and remains a leader in the research and development of ampakines for a variety of central nervous system (CNS) disorders and cannabinoids for the treatment of sleep-related breathing disorders. On March 2, 2020, the Company and the UWM Research Foundation, Inc. (“UWMRF”), an affiliate of the University of Wisconsin-Milwaukee entered into an opti

Biocare Medical LLC, a leading provider of innovative, automated immunohistochemistry reagents and instrumentation, in collaboration with Bethyl Laboratories announces the release of a new rabbit monoclonal antibody, TIGIT [BLR047F] antibody for in vitro diagnostic use in the qualitative identification of the TIGIT protein by immunohistochemistry in formalin-fixed paraffin-embedded human tissues.

Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that company management will be presenting at the 2020 Wedbush PacGrow Healthcare Virtual Conference. The presentation will take place on Tuesday, August 11, 2020 at 2:20 PM EDT. A live webcast of each presentation will be available on the

With an estimated 6 million people worldwide currently living with Parkinson’s, and the disease prevalence expected to double by 2040, the need for more movement disorder specialists to provide expert care and lead research is pressing

With Multiple Applications for its Bone Adhesive Biomaterial under Development, the New Brand will Better Convey the Company’s Overall Goals and Objectives

Medela Cares will donate to U.S.-based organizations supporting Black communities and essential workers during the COVID-19 crisis